Cambridge CRF receives new funding boost for delivery of early stage clinical research

The NIHR Cambridge Clinical Research Facility (CRF) has been…

Taking part in ovarian cancer research

Meet the women who have been participating in vital cancer research in Cambridge.

Cancer drug gives hope in treating heart attacks

A trial supported by the NIHR Cambridge Clinical Research Facility has found a drug used to treat cancer could help with heart attack recovery.

1,000 Covid patients sign up to UK drug trial

A study funded by the NIHR Cambridge BRC and supported by the NIHR Cambridge Clinical Research Facility, has enrolled a thousand Covid patients to find new treatments for the long term consequences of the disease.

Artificial pancreas proves ‘life-changing’ for very young children with type 1 diabetes and their families

An artificial pancreas developed by Cambridge researchers and supported by the NIHR Cambridge CRF, has found it is both safe to use and more effective at managing blood sugar levels in young children than current technology.

NICE prostate guidelines updated based on Cambridge research

A Cambridge developed model to risk-categorise prostate cancer has been added to the NICE guidelines and adopted as standard practice in the NHS. 

Immune responses to COVID booster vaccination; results of an UK-wide clinical trial

Results published in The Lancet for the COV-BOOST study, which was supported by the NIHR Cambridge CRF

Com-COV 3 COVID-19 vaccine study calls on teenager volunteers in Cambridgeshire

Researchers running the University of Oxford-led Com-COV programme have started enrolling young people aged 12 to 16 years old to receive a second dose of a COVID-19 vaccine, including Cambridgeshire.

Positive phase 3 results reported in trial for new Covid-19 vaccine

A clinical trial supported by the NIHR Cambridge CRF for a new vaccine against COVID-19 has received positive Phase 3 results.